Inhibition of ATM/ATR in several p53+/+ but not p53−/− cancer cell lines therefore abrogates the induction of ISGylation components, consistent with genotoxin-induced ISGylation of p53 being promoted by PIKKs via their known role of p53 activation [88,137]. This evidence concerns the gene TP53 and cancer.